Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/02/2010US20100305106 Inhibitors of fatty acid uptake and methods of use
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305101 Leptin genotype and ß-adrenergic agonists
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305074 Niacin-based pharmaceutical compositions
12/02/2010US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305032 Novel GLP-1 Derivatives
12/02/2010US20100305031 Peptide having an extending action for half-life of object peptide in plasma
12/02/2010US20100303936 Method of reducing fat accumulation and inducing weight loss
12/02/2010US20100303924 Process for Producing A Beverage Comprising Cocoa Material with Enhanced Polyphenol Levels
12/02/2010US20100303919 Pharmaceutical compositions comprising fluvastatin
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303855 Method of reducing adverse effects of therapeutic agents for dyslipidemia
12/02/2010US20100303853 Novel Nacl Salt Substitute Agent, Use Thereof and Products Containing Same
12/02/2010US20100303850 Nanocarriers possessing components with different rates of release
12/02/2010US20100303823 Human monoclonal antibodies against interleukin 8 (il-8)
12/02/2010US20100303807 Methods for the treatment of il-1beta related diseases
12/02/2010US20100303797 Use of p97 As An Enzyme Delivery System For The Delivery of Therapeutic Lysosomal Enzymes
12/02/2010US20100303782 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
12/02/2010US20100303763 Method for decreasing abdominal girth by administering a bifidobacterium bacteria
12/02/2010US20100303741 Wolfberries and inflammation
12/02/2010CA2763647A1 Methods of using krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders
12/02/2010CA2763041A1 Compositions and methods for modulating lipid composition
12/02/2010CA2762917A1 Salts of methyl (r)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2761934A1 Lxr modulators
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256115A1 Heteromonocyclic compound and use thereof
12/01/2010EP2256109A1 Apoptosis inhibitor
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2255822A1 The use of the effective section of alkaloids from ramulus mori for preparation of a hypoglycemig agent
12/01/2010EP2255820A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/01/2010EP2255818A1 Oral or enteral composition useful for recovery of physical functions
12/01/2010EP2255816A1 Use of compounds extracted from momordica charantia l. in the manufacture of medicaments for prevention and treatment of diabetes and obesity
12/01/2010EP2255805A1 Deferasirox for the treatment of hereditary hemochromatosis
12/01/2010EP2255674A1 Soybean protein material for patients with renal disease and foods made from the same
12/01/2010EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
12/01/2010EP2254872A2 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/01/2010EP2254865A1 Indole compounds and methods of use thereof
12/01/2010EP2254862A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
12/01/2010EP2254861A1 The 1,3-disubstituted ureas, method of re aration and utilisation thereof
12/01/2010EP2254666A1 2-aminoquinolines as 5-ht5a receptor antagonists
12/01/2010EP2254568A2 Methods and assays for detecting and treating hypoglycemia
12/01/2010EP2254565A1 New use for cannabinoids
12/01/2010EP2254563A2 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc
12/01/2010EP2004604B1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
12/01/2010EP1923065B1 Cholesterol absorption inhibitor
12/01/2010CN201657749U Resveratrol microcapsule
12/01/2010CN1985850B Oral medicine composition for replenishing Ca, Mg and Fe and its preparing method and use
12/01/2010CN1951399B Fur seal oil moleeular distillation method
12/01/2010CN1946698B Pyrazole phenyl derivatives as ppar activators
12/01/2010CN1939472B Detection method of compound preparation for treating diabetes
12/01/2010CN1870983B Compositions and foods for improving lipid metabolism
12/01/2010CN1593460B Nutrient capsule of ass hide glue flavone
12/01/2010CN101903384A [1h-pyrazolo [3, 4-b] pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
12/01/2010CN101903375A Carboxyl- or hydroxyl-substituted benzimidazole derivatives
12/01/2010CN101903352A Substituted 3-hydroxypyridines and pharmaceutical compositions thereof
12/01/2010CN101899471A Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899359A Papaya seed oil and preparation method thereof
12/01/2010CN101899121A Refining method of guava leaf polysaccharide
12/01/2010CN101899048A Salt of (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1- carboxylic acid methyl ester
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899007A Pyridine compound
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101898980A Application of ultrafine powder and nanocrystallization technology in preparation of calcium hydroxybenzosulfonate as raw material
12/01/2010CN101898962A Rhein crystal B-type solid matter, preparation method and use
12/01/2010CN101898961A Parietic acid crystal C type solid matter as well as preparation method and application thereof
12/01/2010CN101898960A Rheinic acid crystal type A solid substance and preparation method and application thereof
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897968A Compound preparation for treating dyslipidemia
12/01/2010CN101897967A Seabuckthorn flavone compound preparation for treating dyslipidemia
12/01/2010CN101897964A Medicament for preventing autoimmune disease
12/01/2010CN101897948A Application of S-nitroso glutathione
12/01/2010CN101897947A Nutritional compositions for controlling blood glucose level
12/01/2010CN101897925A Medicinal composition for treating metabolic syndrome
12/01/2010CN101897914A Drug composition with effect of reducing blood glucose level and preparation method thereof
12/01/2010CN101897861A Medicament for treating diabetes
12/01/2010CN101897833A Chinese medicinal tea for losing weight
12/01/2010CN101897832A Medlar reactant and preparation method thereof
12/01/2010CN101897809A Traditional Chinese medicine for treating diabetic retinopathy
12/01/2010CN101897786A Application of total flavonoids of murraya paniculata leaves in preparing drugs for preventing and treating diabetic nephropathy
12/01/2010CN101897755A Traditional Chinese medicine preparation for regulating fat, invigorating blood circulation and regulating vital energy and preparation method thereof
12/01/2010CN101897735A Ginkgo flavone complex preparation for treating dyslipidemia
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101897717A Chinese medicinal composition for treating diabetes and application
12/01/2010CN101897711A Pharmaceutical composition containing HMG-CoA reductase inhibitor, aspirin, folic acid and nicotinic acid and applications thereof
12/01/2010CN101897710A Medicament composition containing HMG-CoA reductase inhibitor, aspirin and folic acid and application thereof
12/01/2010CN101897708A Sustained-release composition for treating blood lipid dysbolism
12/01/2010CN101897698A Sugar-lowering drug composition containing vildagliptin and B vitamins and application thereof
12/01/2010CN101897697A Sugar-lowering drug composition and application
12/01/2010CN101897696A Sugar-lowering drug composition and application thereof
12/01/2010CN101897694A Simvastatin composite with function of reducing blood fat and preparation method thereof
12/01/2010CN101897690A Pravastatin sodium composition with function of reducing blood fat and preparation method thereof
12/01/2010CN101897689A Application of N-acetyl phenylalanine derivatives to inhibition of urease activity
1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 1298